直到Vosoritide的获批，才让ACH治疗迈入一个全新的靶向治疗时代。它是一种C型利钠肽(CNP)类似物，通过结合NPR-B进而降低FGFR3的活性来促进生长。临床结果试验显示：相较于安慰剂，每日皮下注射15 μg/kg的Vosoritide，受试者平均年身高增加了1.57厘米。
Фото: Константин Михальчевский / РИА Новости，详情可参考Line官方版本下载
[&:first-child]:overflow-hidden [&:first-child]:max-h-full"，更多细节参见heLLoword翻译官方下载
Wordiness: This tool will help you check your writing for long and hard-to-read sentences. It also shows you how to shorten sentences so that they are more concise.